Arteriosclerosis
Not yet recruitingStudy of Olpasiran to prevent first major cardiovascular events in people with high levels of lipoprotein(a)
- Disease:Arteriosclerosis
- Substances:–
Hungary- Participants:18–64 years · 65+ years
- Sponsor:Amgen Inc.
Rare diseases
Investigational molecules
Locations
Back to Hungary34 clinical trials in Godollo, Hungary. Every trial is listed in the EU Clinical Trials Register and updated daily.
Hungary
Hungary
Hungary
Hungary
Hungary
Hungary
Hungary
Hungary
Hungary
Hungary
Hungary
HungaryThe busiest research cities in the country
What the registry says about research in the country
Extensive research focusing on chronic obstructive pulmonary disease (COPD) and various treatment approaches, including triple therapy combinations and novel bronchodilators. Studies evaluate the effectiveness of different medications in reducing exacerbations and improving lung function.
Multiple trials examining long-term safety and efficacy of innovative therapies for moderate to severe COPD patients.
Comprehensive research into severe asthma treatments, including investigations of new biological therapies and innovative inhaler formulations. Studies focus on reducing exacerbations and improving control in patients with moderate to severe asthma.
Clinical trials exploring both established and novel treatment approaches for various asthma phenotypes.
Targeted research addressing eosinophilic asthma and chronic cough conditions. Studies evaluate innovative treatments including long-acting medications and targeted therapies for specific patient populations.
Investigations focus on developing specialized treatments for patients with specific respiratory conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.